Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:385 |
|---|---|
| Enthalten in: |
Naunyn-Schmiedeberg's archives of pharmacology - 385(2012), 4 vom: März, Seite 385-397 |
| Beteiligte Personen: |
Schulte, Kirsten [VerfasserIn] |
|---|
| Umfang: |
12 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1890831662 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1890831662 | ||
| 003 | DE-627 | ||
| 005 | 20230713032300.0 | ||
| 007 | tu | ||
| 008 | 120315s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw120314_1 |
| 035 | |a (DE-627)OLC1890831662 | ||
| 035 | |a (DE-599)GBVOLC1890831662 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Schulte, Kirsten |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor |
| 264 | 1 | |c 2012 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Steingrüber, Nina |4 oth | |
| 700 | 1 | |a Jergas, Bernd |4 oth | |
| 700 | 1 | |a Redmer, Agnes |4 oth | |
| 700 | 1 | |a Kurz, Christina Maria |4 oth | |
| 700 | 1 | |a Buchalla, Rainer |4 oth | |
| 700 | 1 | |a Lutz, Beat |4 oth | |
| 700 | 1 | |a Zimmer, Andreas |4 oth | |
| 700 | 1 | |a Schlicker, Eberhard |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Naunyn-Schmiedeberg's archives of pharmacology |d Berlin : Springer, 1972 |g 385(2012), 4 vom: März, Seite 385-397 |w (DE-627)129297666 |w (DE-600)121471-8 |w (DE-576)014490692 |x 0028-1298 |7 nnns |
| 773 | 1 | 8 | |g volume:385 |g year:2012 |g number:4 |g month:03 |g pages:385-397 |g extent:12 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_287 | ||
| 912 | |a GBV_ILN_2004 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4277 | ||
| 912 | |a GBV_ILN_4306 | ||
| 951 | |a AR | ||
| 952 | |d 385 |j 2012 |e 4 |c 3 |h 385-397 |g 12 | ||